17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial

BACKGROUND: Progestational agents may reduce the risk of preterm birth in women with various risk factors. We sought to test the hypothesis that a weekly dose of 17-hydroxyprogesterone caproate (17P) given to women with preterm rupture of the membranes (PROM) will prolong pregnancy and thereby reduc...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Combs, C Andrew, Garite, Thomas J, Maurel, Kimberly, Mallory, Kimberly, Edwards, Rodney K, Lu, George, Porreco, Richard, Das, Anita
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3260323/
https://ncbi.nlm.nih.gov/pubmed/22206581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-4-568
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky